Sign up to save your podcasts
Or
Share Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy
Editor-in-Chief Cecelia E. Schmalbach, MD, MSc, is joined by senior author David Goldenberg, MD, to discuss role of estrogen in developing thyroid malignancy as outlined in the paper "Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy" which published in the April 2025 issue of Otolaryngology–Head and Neck Surgery. They talk about the risk of thyroid cancer for biological males taking estrogen compared to men not undergoing hormone therapy and women.
Click here to read the full article.
View all episodes
By AAO-HNSF
4.1
1818 ratings
Editor-in-Chief Cecelia E. Schmalbach, MD, MSc, is joined by senior author David Goldenberg, MD, to discuss role of estrogen in developing thyroid malignancy as outlined in the paper "Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy" which published in the April 2025 issue of Otolaryngology–Head and Neck Surgery. They talk about the risk of thyroid cancer for biological males taking estrogen compared to men not undergoing hormone therapy and women.
Click here to read the full article.
More shows like OTO Journal
View all
This American Life
90,960 Listeners
Radiolab
43,864 Listeners
Freakonomics Radio
32,020 Listeners
NEJM This Week
324 Listeners
White Coat Investor Podcast
2,439 Listeners
The Daily
112,502 Listeners
Up First from NPR
56,514 Listeners
JAMA Otolaryngology–Head & Neck Surgery Author Interviews
6 Listeners
The Peter Attia Drive
8,618 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,911 Listeners
Voices of Otolaryngology
11 Listeners
BackTable ENT
55 Listeners
The Ezra Klein Show
15,973 Listeners
Head and Neck Innovations
12 Listeners
The Economics of Everyday Things
1,649 Listeners